Unnikrishnan, A., Deshpande, N., Verma, A., Kumari, A., Richards, L., Knezevic, K., . . . Pimanda, J. (2017). Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes. Cell Press.
Chicago Style (17th ed.) CitationUnnikrishnan, A., et al. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. Cell Press, 2017.
MLA引文Unnikrishnan, A., et al. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. Cell Press, 2017.
警告：這些引文格式不一定是100％准確.